Pharmaceuticals, Biotechnology and Life Sciences
— Oisín closes $3 million financing as it continues to move toward the clinic — SEATTLE–(BUSINESS WIRE)–Oisín Biotechnologies, a privately…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Triplet Therapeutics, Inc., a biotechnology company harnessing new insights from human genetics to develop transformative treatments for repeat…
— Record Fourth-Quarter 2019 Net Sales of $363.5 Million Driven by 14 Percent Growth in the Orphan and Rheumatology Segment;…
Two of three dose cohorts in Phase 2 CMV vaccine (mRNA-1647) dose-confirmation study completed enrollment; third and final cohort rapidly…
RIOMET ER™ (metformin hydrochloride for extended-release oral suspension) is the first and only U.S. FDA-approved extended-release liquid formulation of metformin…
DUBLIN–(BUSINESS WIRE)–The “CNS Therapeutics – Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering. The global market…
DUBLIN–(BUSINESS WIRE)–The “2nd Annual Cell Therapy Bioprocessing Conference” conference has been added to ResearchAndMarkets.com’s offering. Over the last decade, the…
Data shows 14.8% women and 7.3% racial minorities on boards of UK life sciences companies LONDON–(BUSINESS WIRE)–#2020lifesciencesUK–A study of 132…
− Investigational medicine TAK-062 is an oral computationally engineered super glutenase designed to improve the digestion of gluten − Successful…
LONDON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that KALYDECO® (ivacaftor) will be available to eligible patients with cystic fibrosis…